In the present study, we demonstrate ␥-interferon (␥-IFN)-inducible scavenger receptor A (SR-A) mRNA expression during the early stages of THP-1 and blood monocyte differentiation. Predominant induction of SR-A type II mRNA parallels the increased accumulation of cholesteryl esters under these conditions. A potential signal transducer and activator of transcription (STAT1) binding site (␥-interferon activation site) in the SR-A promoter demonstrates ␥-IFN-inducible DNA binding activity and is most likely responsible for the ␥-IFNdependent expression of an SR-A promoter-luciferase fusion construct. In contrast, ␥-IFN inhibits SR-A expression in mature macrophages as well as after prolonged ␥-IFN incubation of THP-1 monocytes. Taken together, these results demonstrate opposite effects of ␥-IFN on SR-A expression and activity during the early versus late stages of monocyte maturation. ␥-IFN-induced STAT1 activation, leading to increased SR-A expression, could therefore play an important role in the initial steps of foam cell formation and xanthomatosis. (Arterioscler Thromb Vasc Biol. 2001;21:825-831.) Key Words: scavenger receptor type A Ⅲ ␥-interferon Ⅲ STAT1␣ Ⅲ GAS element Ⅲ macrophage activation
M onocyte-derived macrophages are implicated in the development of foam cells of atherosclerotic lesions. 1 The human macrophage scavenger receptor A (SR-A) binds and internalizes modified LDL, which ultimately results in the accumulation of cholesterol esters in macrophages. 2 These results, together with the elevated plasma cholesterol levels and the reduced size of atherosclerotic lesions seen in SR-A/apolipoprotein E (apoE) double-knockout mice, 3 have led to the hypothesis that SR-A plays an important role in the formation of foam cells during the early stages of atherosclerosis.
In humans, SR-A expression is almost entirely restricted to macrophages, and it increases during monocyte maturation. 4 The 2 SR-A mRNA isoforms result from alternative splicing of the same transcript from a single gene, 5 but the functional significance of the 2 isoforms remains unknown. 6 Previous studies have demonstrated that during early monocyte differentiation, SR-A expression is stimulated by macrophage colony-stimulating factor. 7 This transcriptional activation of the SR-A gene is thought to be mediated by members of the activator protein (AP)-1 and ets family of transcription factors. 8, 9 In contrast, ␥-interferon (␥-IFN), transforming growth factor-␤1, and tumor necrosis factor-␣ have been shown to inhibit SR-A expression in mature macrophages. 10 -13 Recent findings have demonstrated that ␥-IFN can inhibit transcription of the macrophage SR-A gene by antagonizing the AP-1 and ets transcription factors as a result of competition between AP-1/ets and a signal transducer and activator of transcription (STAT1) for limiting amounts of the transcriptional cofactors CREB-binding protein and p300. 11 We have recently reported that SR-A-overexpressing monocytes from a normolipidemic patient with xanthomatosis demonstrated elevated STAT1␣ and ␥-IFN-inducible protein-10 (IP-10) expression. 14 Similar results were obtained from a number of subjects with familial hypercholesterolemia, who frequently develop xanthomatosis. 14 We now report that ␥-IFN regulates SR-A expression in a differentiation-dependent manner in THP-1 and bloodderived monocytes. In agreement with previous reports, ␥-IFN exhibits an inhibitory effect on SR-A mRNA expression in mature macrophages. 10, 11 In contrast, ␥-IFN stimulates SR-A expression at early stages of monocyte differentiation. Gel retardation and transfection experiments suggest that ␥-IFN-inducible STAT1 binding to a potential STAT1 element (␥-interferon activation site [GAS]) at position Ϫ133 to Ϫ125 (SR-Ap) in the SR-A promoter is in part responsible for the induction of SR-A expression and activity in ␥-IFNactivated monocytes. Our results explain previously discordant findings on the role of ␥-IFN in SR-A regulation and provide the first demonstration that a GAS in the SR-A promoter has a regulatory function on SR-A activity.
Methods

Cell Culture
Human THP-1 monocytes were grown in RPMI 1640 medium containing 10% heat-inactivated fetal calf serum. To promote differentiation, monocytes were incubated with phorbol 12-myristate-13acetate (PMA 0.1 g/mL, Sigma). Human recombinant ␥-IFN (Gibco-BRL) was added to PMA-induced THP-1 cells at a concentration of 25 ng/mL of medium (175 U/mL). Blood-derived monocytes were isolated from healthy normolipidemic laboratory personnel (ages 30 to 59; 7 men and 5 women) as described. 15 This research was approved by the Institutional Ethics Committee, and informed consent was obtained from all subjects.
RNA Extraction and Northern Blot Analysis
Total RNA was isolated from 5 to 8ϫ10 6 THP-1 cells with Trizol reagent (Gibco-BRL) and analyzed by Northern blotting as described. 14 
RT-PCR Analysis
Total RNA was reverse-transcribed (RT) with murine Moloney leukemia virus reverse transcriptase (Gibco-BRL) as described. 14, 15 Simultaneous amplification of a 290-bp SR-A cDNA fragment and a 376-bp glyceraldehyde 3-phosphate dehydrogenase cDNA fragment was performed in duplicate by using primers labeled with Hex fluorescence (University of Calgary Core DNA Services, Calgary, Alberta, Canada) as described. 15 Determination of STAT1␣ and IP-10 transcript levels was performed by semiquantitative polymerase chain reaction (PCR) analysis and has been described in detail 14 (also see http://www.atvb.ahajournals.org).
Gel Mobility Shift Assays
Preparation of nuclear extracts has been previously described in detail. 14 Oligonucleotides comprising potential GAS elements from Ϫ133 to Ϫ125 (SR-Ap: 5Ј-TTAGATTTTGCAAAACGTC-3Ј), Ϫ813 to Ϫ805 (SR-Ad: 5Ј-CTCCTGGGTTCAAGCAATTC-3Ј), and the AP-1 binding site from Ϫ67 to Ϫ50 (5Ј-AATGTGTCATTTCCTTTC-3Ј) of the human SR-A gene 8, 9 were used to identify the binding of transcription factors. GAS elements from the human GTP-binding protein and IP-10 promoter regions 14 served as STAT1 binding controls. One to 2 microliters of nuclear extract (4 g protein) and [␥-32 P]dATPlabeled (Amersham, 800 Ci/mmol) double-stranded oligonucleotides (0.5 ng, 2ϫ10 5 counts per minute) were incubated for 30 minutes, and protein-DNA complexes were electrophoresed on 6% polyacrylamide gels. A 100-fold excess of unlabeled double-stranded human GTPbinding protein and IP-10 GAS elements or a synthetic AP-1 oligonucleotide (5Ј-GATCCGATGAGTCAGCCA-3Ј) 14 was added in some experiments.
Transfection of THP-1 Cells
Human SR-A promoter fragments from positions Ϫ290 to ϩ54 (344 bp, pSRA-290) and from Ϫ116 to ϩ54 (170 bp, pSRA-116) were cloned into pGL3-Basic (Promega). Cells (4ϫ10 7 ) were cotransfected with 32 g of pSRA-290 or pSRA-116 together with 1 g of ␤-galactosidase reporter plasmid as an internal control by using the diethylaminoethyl-dextran method (Stratagene). Forty-eight hours after transfection, 10 7 cells/mL were plated and incubated for 24 to 72 hours at 37°C under various conditions. Luciferase activity was assayed with the Promega luciferase assay system with a Berthold LB 953 luminometer and normalized to the ␤-galactosidase standard.
Lipid Loading of Cells
Preparation and acetylation (Ac) of LDL were performed and confirmed by agarose gel electrophoresis as described. 14, 15 Ac-LDL (50 g/mL) was added to PMA-activated THP-1 cells (with or without ␥-IFN) in RPMI 1640 containing 10% lipoprotein-deficient serum. Cells were incubated for 24 hours at 37°C, washed with phosphate-buffered saline, and collected for lipid extraction. 17 Lipids were analyzed by capillary gas chromatography 18 (for details of lipid analysis, see http://www.atvb.ahajournals.org).
Accumulation of 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyane (DiI) Ac-LDL (L-3484, Molecular Probes) was analyzed by fluorescence-activated cell sorting flow cytometry (FACScan, Becton-Dickinson) at 555 nm as described. 15 PMA-activated THP-1 cells (10 6 ) were incubated in 10% lipoprotein-deficient serum with or without ␥-IFN for 24 hours, followed by incubation with 10 g/mL DiI-Ac-LDL for 1 hour at 37°C. Cells were washed 3 times with ice-cold phosphate-buffered saline and subjected to FACScan analysis. 15 Ac-LDL was radiolabeled with 125 I by the iodine monochloride method. 19 THP-1 cells (2 to 3ϫ10 5 ) were preincubated with lipoprotein-deficient medium for 30 minutes at 37°C, and 125 I-Ac-LDL was added at 4 to 5 g/mL (in triplicate) for 24 to 72 hours at 37°C. A 50-fold excess of unlabeled Ac-LDL was added to every third sample to determine nonspecific uptake and degradation of 125 I-Ac-LDL. 20 The remaining cells were lysed with 0.1N NaOH, and total cell protein content was determined. 17
Results
␥-IFN Induces SR-A Expression During Early Differentiation of Monocytes
SR-A mRNA levels were determined by RT-PCR with the use of primers corresponding to exons 1 to 3, which are common to both isoforms of SR-A. 15 As reported previously, 9, 13 SR-A mRNA expression was markedly enhanced in PMA-differentiated THP-1 monocytes compared with untreated controls ( Figures 1A and 2A ). Addition of ␥-IFN resulted in a significant increase (PϽ0.01) of SR-A expression compared with PMA-activated cells ( Figures 1A and 2B ) and was most pronounced (4-fold) at earlier time points (6 to 12 hours). When THP-1 monocytes were preincubated with PMA for various times (6 to 144 hours) followed by ␥-IFN incubation for an additional 24 hours, SR-A expression increased only 2.0-to 2.5-fold during the early stages of PMA activation (PϽ0.01 at 6 hours) and decreased after prolonged incubation with PMA ( Figure 1B ).
Differential Stimulation of SR-A Isoforms in ␥-IFN-Activated Monocytes
␥-IFN-inducible expression of SR-A during early monocyte differentiation was confirmed by Northern blotting ( Figure  2 ). During the first 48 hours of PMA activation, a constant increase of the dominantly expressed SR-AII, as well as the SR-AI isoform, was observed ( Figure 2A, lanes 1 through 3) . In contrast, PMA incubation for 4 to 7 days reduced SR-AI and SR-AII expression levels 1.5-and 2-fold, respectively, compared with 24-hour PMA-activated THP-1 cells ( ␥-IFN-induced SR-A mRNA expression peaked after 12hour preincubation with PMA ( Figure 2C, lane 3) , similar to the results obtained from RT-PCR analysis (see Figure 1B) and indicating that maximum ␥-IFN-mediated SR-A induction occurs within the first 12 hours of PMA activation. In contrast, prolonged PMA prestimulation resulted in a ␥-IFNmediated repression of both SR-AI and SR-AII mRNA levels ( Figure 2C , lanes 4 and 5). Because the duration of PMA incubation mimics the differentiation status of THP-1 cells, our results suggest that the time-related effects on total SR-A expression reflect the sum of differential ␥-IFN responses on each SR-A mRNA isoform in early and later stages of monocyte maturation.
␥-IFN Induces SR-A Expression During Maturation of Blood-Derived Monocytes
Human blood-derived monocytes (nϭ12) were analyzed to confirm the potential relevance of ␥-IFN signaling on SR-A expression during blood monocyte maturation (Figure 3 ). Owing to the variation in SR-A expression among monocytes from different subjects, 15 SR-A mRNA increased by 8.5-to 22-fold during maturation of macrophages, depending on the individual analyzed. In contrast and similar to previous findings, 10 prolonged incubations with ␥-IFN of more mature macrophages resulted in SR-A mRNA expression levels that were reduced by 43% to 80% compared with the respective control macrophages analyzed (Pϭ0.01). These results are correlated with the data obtained from PMA-activated THP-1 monocytes (see Figure 1 ) and indicate that ␥-IFN exerts opposite effects on SR-A expression during early versus late stages of blood monocyte maturation.
Induction of SR-A Activity in ␥-IFN-Activated
THP-1 Monocytes
To determine that upregulation of SR-A mRNA corresponded to increased SR-A receptor activity, we measured lipid accumulation and Ac-LDL degradation in ␥-IFN-activated and PMA-treated THP-1 monocytes ( Table 1) . ␥-IFN activation of PMA-differentiated THP-1 monocytes showed an almost 2-fold increase in cholesteryl ester content after lipid loading (Table 1A ; 88.6Ϯ10.4 nmol cholesteryl ester-derived cholesterol per mg cell protein; Pϭ0.03), a 2-fold increase in DiI-Ac-LDL accumulation (Table 1B) , and a 1.5-fold increase in 125 I-Ac-LDL degradation (Table 1C; 154.9Ϯ26.7 ng/mg cell protein; Pϭ0.02) compared with PMA-induced controls. These results indicate that ␥-IFNinduced SR-A mRNA expression leads to elevated SR-A activity during the early stages of monocyte differentiation.
Expression of Other ␥-IFN-Inducible Genes in THP-1 Monocytes
To compare the ␥-IFN-regulated SR-A expression pattern with other well-known ␥-IFN-responsive genes, we examined the expression of STAT1␣ and IP-10, a STAT1responsive gene 14 (see Figure I at http://www.ahajournals.org). In these experiments, the ␥-IFN-inducible expression patterns of STAT1␣ and IP-10 in THP-1 and blood-derived monocytes were similar to the SR-A expression analysis described above and indicated that comparable transcriptional mechanisms are involved in the regulation of these genes.
Identification of a Potential STAT1 Binding Element in the SR-A Promoter
The observed expression pattern of SR-A (Figures 1 through  3 ) and the increased STAT1␣ binding activity in ␥-IFN-ac-tivated THP-1 monocytes 14 suggested the presence of potential STAT1 binding sites (GAS) in the 5Ј regulatory region of the human SR-A gene. We identified 2 putative GASs, located Ϫ125 to Ϫ133 (SR-Ap) and Ϫ805 to Ϫ813 (SR-Ad) upstream from the transcriptional SR-A initiation site, and performed gel retardation assays with nuclear extracts from THP-1 cells and human blood-derived monocytes (Figure 4) . The SR-Ad oligonucleotide did not demonstrate ␥-IFNinducible binding of proteins (data not shown). In contrast, extracts from PMA-activated THP-1 monocytes showed ␥-IFN-inducible binding activity to the STAT1 recognition site SR-Ap ( Figure 4A; compare lanes 4 and 5) . This ␥-IFN-inducible binding activity was competed efficiently at all time points analyzed by the human GTP-binding protein and IP-10 STAT1 14 binding elements ( Figure 4A , lanes 1 and 2 at tϭ9 hours). Binding activity peaked after 12 hours ( Figure 4A, lane 6) , whereas prolonged incubation with ␥-IFN resulted in reduced binding ( Figure 4A, lanes 7 and 8) . Nuclear extracts from blood-derived monocytes also demonstrated ␥-IFN-inducible binding at the early stages of maturation only ( Figure 4B) . These results indicate that ␥-IFNinducible STAT1 binding to the SR-Ap GAS in the SR-A promoter can occur during both THP-1 cell and blood monocyte differentiation.
Differential Regulation of the SR-A Promoter in ␥-IFN-Activated Monocytes
THP-1 cells were transfected with a human SR-A promoterluciferase fusion construct including both the putative GAS ϩPMA/ϩ␥-IFN 154.9Ϯ26.7* For A, 5ϫ10 6 THP-1 monocytes were incubated with or without PMA and ␥-IFN overnight, followed by a 24-hour incubation with 50 g/mL Ac-LDL. Cells were collected for lipid extraction, and cholesterol and cholesteryl esters were determined as described in Methods. *Pϭ0.03.
Increased Accumulation of Cholesteryl Esters (A), DiI-Ac-LDL (B), and 125 I-Ac-LDL Protein Degradation (C) in ␥-IFN-Activated THP-1 Cells
For B, 5ϫ10 6 THP-1 monocytes were incubated with PMA for 6 hours followed by a 24-hour incubation with or without ␥-IFN and 10 g/mL DiI-Ac-LDL. Cells were then subjected to flow cytometry as described in Methods. Fluorescence intensity of DiI-Ac-LDL-loaded cells is given in percentage and represents the mean of duplicate samples.
For C, 2ϫ10 5 THP-1 monocytes were incubated with or without PMA and ␥-IFN and 4 to 5 g/mL 125 I-Ac-LDL as indicated. Media were collected and protein degradation was determined as described in Methods. The values represent the meanϮSD of 3 separate experiments with triplicate samples. *Pϭ0.02. and AP-1 sites (pSRA-290) or a deletion mutant containing the AP-1 site only (pSRA-116) ( Figure 5 ). Overnight incubation of transfected PMA-activated THP-1 monocytes with ␥-IFN resulted in a 3.1-fold induction of transcriptional activity of the 290-bp SR-A promoter compared with PMAactivated controls ( Figure 5; PϽ0.01) . Deletion of the putative SR-Ap GAS in the SR-A promoter construct pSRA-116 led to a complete loss of ␥-IFN response after PMA activation. In contrast, but in agreement with other findings, 10, 11 transfection of the 290-bp SR-A promoter-luciferase fusion construct followed by prolonged (3-day) incubation with ␥-IFN resulted in a 3.9-fold reduction of luciferase expression compared with PMA controls (data not shown). Taken together, these data strongly indicate that ␥-IFN-induced STAT1 binding to the proximal SR-A promoter region is in part responsible for the increased SR-A expression in PMAdifferentiated THP-1 monocytes.
Discussion
A number of cytokines have been shown to regulate SR-A expression and activity in vitro. 8 -13 The presence of ␥-IFNsecreting T lymphocytes in atherosclerotic lesions 21 and the important role of ␥-IFN for monocyte activation have resulted in several studies that have analyzed the effect of ␥-IFN on SR-A expression in macrophages. In those experiments, prolonged incubation of PMA-differentiated THP-1 macrophages or mature primary macrophages with ␥-IFN resulted in the downregulation of SR-A expression, followed by reduced Ac-LDL binding and internalization. 10, 11 In this study, we have demonstrated that ␥-IFN can exert opposite effects on SR-A expression, depending on the differentiation status of monocytes and the duration of ␥-IFN activation. SR-A mRNA expression was increased after a 24-hour ␥-IFN activation of THP-1 monocytes preincubated with PMA for 6 to 12 hours. Results from ␥-IFN-activated (Ͻ48 hours) human blood-derived monocytes confirm these observations and can be correlated with the increased Ac-LDL degradation of human macrophages after a 22-hour incubation with ␥-IFN. 22 The dominantly expressed SR-AII mRNA isoform seems responsible for the ␥-IFN-induced SR-A activity in ␥-IFNand PMA-activated THP-1 monocytes compared with controls.
Similar to previous findings, 10, 11 ␥-IFN was discovered to inhibit SR-A expression in mature blood-derived macrophages but does not stimulate SR-A mRNA levels in THP-1 cells after prolonged PMA activation. The complex response in SR-A expression after short-versus long-term exposure to ␥-IFN cannot be explained by a transcriptional mechanism only. ␥-IFN-mediated stimulation of SR-A, affecting pre- dominantly the SR-AII isoform, could reflect functional specificities of the 2 isoforms in acute and chronic exposure to ␥-IFN. Furthermore, the diminution of SR-A expression after chronic ␥-IFN exposure could be attributable in part to an mRNA-destabilizing effect similar to the tumor necrosis factor-␣-mediated posttranscriptional inhibition of SR-A expression in THP-1 cells. 13 The potential STAT1 binding site, located at positions Ϫ125 to Ϫ133 of the SR-A promoter, demonstrated ␥-IFNinducible binding of nuclear proteins. This binding is correlated with ␥-IFN-inducible expression of the endogenous SR-A gene and activation of the SR-A promoter reporter gene construct. These findings coincide with maximal induction of the ␥-IFN receptor in PMA-activated THP-1 cells under these conditions, 23 demonstrating an enhanced capacity of monocytes to respond to ␥-IFN. Our results strongly suggest that STAT1 binding to the SR-A promoter is partly responsible for ␥-IFN-mediated activation of the SR-A promoter. Although transcriptional activation by AP-1 is thought to be inhibited by STAT1, we did not observe reduced binding of AP-1 to the SR-A AP-1/ets motif after ␥-IFN activation during early monocyte maturation (data not shown). These findings suggest that the basal AP-1 activity-dependent transcriptional machinery is not negatively affected by STAT1 activation after a short ␥-IFN incubation. The ␥-IFNand PMA-inducible expression of an SR-A promoter-luciferase fusion construct confirms these observations and indicates that adjacent AP-1/ets and STAT1 binding sites on the SR-A promoter may cooperate to induce SR-A expression in early differentiating monocytes. To the contrary, and as shown previously, 11 prolonged ␥-IFN exposure leads to inhibition of AP-1/ets transcription factors, which results in reduced SR-A promoter activity in mature macrophages.
The opposite effects of ␥-IFN on SR-A expression during early versus late stages of monocyte maturation could explain some of the conflicting results obtained from studies on the potential role of ␥-IFN in the pathogenesis of atherosclerosis. Decreased SR-A expression in mature macrophages 10, 11 and inhibition of smooth muscle cell proliferation 24 could reflect the antiatherogenic properties of ␥-IFN. Conversely, ␥-IFN potentiates atherosclerosis in apoE-knockout mice 25 and stimulates vascular cell adhesion molecule-1 expression in rabbit aortic endothelium. 26 A critical step in the initiation of atherosclerosis is the recruitment of monocytes to the arterial wall. 27 Therefore, the stimulatory effect of ␥-IFN on SR-A expression could indicate that SR-A might not function as a lipoprotein receptor during the early stages of monocyte differentiation but rather as an adhesion molecule, as proposed by Fraser and coworkers. 28 ␥-IFN-inducible STAT1 activity in the promoter of the intercellular adhesion molecule-1 gene stimulates adhesion of monocytes 29 and suggests a similar role of STAT1 for SR-A regulation and function. Future experiments should be carried out to investigate SR-A's function as part of a general STAT1-mediated transcriptional mechanism to induce adhesion of monocytes and promote their differentiation to macrophages.
